Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more

GREY:COTQF - Post Discussion

Cotinga Pharmaceuticals Inc > Cotinga Pharmaceuticals halted open
View:
Post by MiningMasterAu on Oct 07, 2019 10:55am

Cotinga Pharmaceuticals halted open

Cotinga Pharmaceuticals halted open

2019-10-07 06:01 MT - Halt Trading

Cotinga Pharmaceuticals Corp. has been halted at the open on Oct. 7, 2019, following a cease trade order.

© 2019 Canjex Publishing Ltd. All rights reserved.

Comment by johnney on Nov 23, 2019 5:45pm
This post has been removed in accordance with Community Policy